EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field

Matthew J Slarve, Christine Tkaczyk, Michael P Doyle, Timothy J Break, Alexander B Smith, Galit Alter, Brian Luna, Brad Spellberg, Antonio DiGiandomenico

BioDrugs · 2026-07 · 40 (4) · 641-671

DOI: 10.1007/s40259-026-00787-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioDrugs, online erschienen am 15.06.2026. Verfasst von Matthew J Slarve und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Immune Therapeutics Department, University of Southern California Keck School of Medicine, 1441 Eastlake Ave, NTT 6419, Los Angeles, C…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Bacterial Infections, Anti-Bacterial Agents. Die Arbeit nennt 334 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ever-increasing trend of antibiotic resistance necessitates new therapeutic strategies for fighting infection. Standing on decades of extensive research and development, monoclonal antibodies have great promise for treating antibiotic-resistant bacterial infections. In this comprehensive review of the field, we summarize the rapidly emerging field of monoclonal therapeutics that offer alternative approaches to target bacterial pathogens that pose critical concern to human health. Organizing the findings by species and by molecular target, we discuss antibodies that have demonstrated therapeutic potential as well as those that did not provide efficacy, highlighting new insights for the design and discovery of highly effective therapeutics for the future. Furthermore, we discuss the latest advances in molecular biology that have revolutionized the implementation, efficacy, and utility of monoclonal antibodies as therapeutics, and that continues to drive what will be an exciting era for antibacterial monoclonal antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalBacterial InfectionsAnti-Bacterial AgentsHumansAnimalsBacteriaDrug Resistance, Bacterial

Substanzen

Antibodies, MonoclonalAnti-Bacterial Agents

Autor:innen und Institutionen

  • Immunology and Immune Therapeutics Department, University of Southern California Keck School of Medicine, 1441 Eastlake Ave, NTT 6419, Los Angeles, CCA 90033A, USA. matt.slarve@gmail.com.
  • Early Infectious Disease, Biopharmaceuticals Business Unit, AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, USA.
  • Immunology and Immune Therapeutics Department, University of Southern California Keck School of Medicine, 1441 Eastlake Ave, NTT 6419, Los Angeles, CCA 90033A, USA.
  • Los Angeles General Medical Center, Los Angeles, CA, USA.
  • Early Infectious Disease, Biopharmaceuticals Business Unit, AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, USA. antonio.digiandomenico@astrazeneca.com.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Slarve, M. J., Tkaczyk, C., Doyle, M. P., Break, T. J., Smith, A. B., Alter, G., Luna, B., Spellberg, B., & DiGiandomenico, A. (2026). Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field. BioDrugs, 40(4), 641-671. https://doi.org/10.1007/s40259-026-00787-9

Vancouver

Slarve MJ, Tkaczyk C, Doyle MP, Break TJ, Smith AB, Alter G, et al. Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field. BioDrugs. 2026;40(4):641-671. doi:10.1007/s40259-026-00787-9

BibTeX
@article{Slarve2026,
  author = {Slarve, Matthew J and Tkaczyk, Christine and Doyle, Michael P and Break, Timothy J and Smith, Alexander B and Alter, Galit and Luna, Brian and Spellberg, Brad and DiGiandomenico, Antonio},
  title = {Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field},
  journal = {BioDrugs},
  year = {2026},
  volume = {40},
  number = {4},
  pages = {641--671},
  doi = {10.1007/s40259-026-00787-9}
}
Kostenlos starten →